Hospital costs of ischemic stroke and TIA in the Netherlands

Neurology

Volumn 84, Issue 22, 2015, Pages 2208-2215

  Buisman, Leander R ^a   Tan, Siok Swan ^a   Nederkoorn, Paul J ^b   Koudstaal, Peter J ^c   Redekop, William K ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CAROTID ENDARTERECTOMY; COST OF ILLNESS; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTPATIENT; PATIENT CARE; PRIORITY JOURNAL; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; ECONOMICS; FOLLOW UP; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; RETROSPECTIVE STUDY; STROKE; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; STROKE;

EID: 84930351434     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001635     Document Type: Article

References (22)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008;371:1612-1623.
2. Minkman MM, Schouten LM, Huijsman R, van Splunteren PT. Integrated care for patients with a stroke in the Netherlands: results and experiences from a national Breakthrough Collaborative Improvement project. Int J Integr Care 2005;5:e14.
3. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309: 2480-2488.
4. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
5. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243.
6. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 patients with prior stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
7. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
8. Bergman L, van der Meulen J, Limburg M, Habbema DF. Cost of medical care after first-ever stroke in the Netherlands. Stroke 1995;26:1830-1836.
9. Evers SM, Engel GL, Ament AJ. Cost of stroke in the Netherlands from a societal perspective. Stroke 1997;28: 1375-1381.
10. Van Exel J, Koopmanschap MA, Van Wijngaarden JD, Scholte Op Reimer WJ. Costs of stroke and stroke services: determinants of patient costs and a comparison of costs of regular care and care organised in stroke services. Cost Eff Resour Alloc 2003;1:2.
11. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: the Erlangen Stroke Project. Stroke 2006;37:1179-1183.
12. Gioldasis G, Talelli P, Chroni E, Daouli J, Papapetropoulos T, Ellul J. In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece. Acta Neurol Scand 2008;118:268-274.
13. Cadilhac DA, Carter R, Thrift AG, Dewey HM. Estimating the long-term costs of ischemic and hemorrhagic stroke for Australia: new evidence derived from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2009;40:915-921.
14. Yoneda Y, Okuda S, Hamada R, et al. Hospital cost of ischemic stroke and intracerebral hemorrhage in Japanese stroke centers. Health Policy 2005;73:202-211.
15. Van Straten A, Van der Meulen JH, Van den Bos GA, Limburg M. Length of hospital stay and discharge delays in stroke patients. Stroke 1997;28:137-140.
16. Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care 2012;28:152-158.
17. Dutch Healthcare Authority (in Dutch: Nederlandse Zorgauthoriteit, NZa). NZa Zorgproducten Tariefapplicatie. Available at: http://dbc-zorgproducten-tarieven.nza.nl/nzaZpTarief/ZoekfunctieDbc.aspx. Accessed May 1, 2013.
18. Statistics Netherlands (in Dutch: Central Bureau voor de Statistiek, CBS). CBS Statline. Available at: http://statline. cbs.nl. Accessed May 1, 2013.
19. European Central Bank. ECB: Euro foreign exchange reference rates. Available at: https://www.ecb.europa.eu/stats/exchange/eurofxref/html/index.en.html. Accessed October 24, 2014.
20. Organisation for Economic Co-operation and Development (OECD). OECD Territorial Reviews: Randstad Holland, Netherlands. Paris: OECD; 2010.
21. Chandratheva A, Geraghty OC, Luengo-Fernandez R, Rothwell PM. ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke 2010;41:851-856.
22. O'Donnell MJ, Xavier D, Liu L, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010;376:112-123.